Frontlight ResearchEarly access
Trial site
Investigaciones en Patologias Respiratorias
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis6 trials
- Asthma4 trials
- Heart failure2 trials
- COPD1 trial
- Rheumatoid arthritis1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 27 trials
- Phase 36 trials
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- United Therapeutics3 trials
- Avalyn Pharma Inc.2 trials
- Boehringer Ingelheim2 trials
- Upstream Bio Inc.2 trials
- Genentech, Inc.1 trial
- and 3 more
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Active, not recruiting
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Idiopathic pulmonary fibrosis3 recruiting
- Heart failure2 recruiting
- Asthma1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026